Mesothelioma Information and Support - Comprehensive Mesothelioma Information

Mesothelioma palliative care serves as a vital approach in alleviating both the physical and emotional symptoms associated with this aggressive cancer. With the objective of enhancing patients' quality of life,...

Keytruda (pembrolizumab) is an immunotherapy drug developed by Merck & Co. It's primarily known for its use in treating various forms of cancer, particularly those that are associated with certain...

Immunotherapy has emerged as a significant approach in the treatment of mesothelioma. One notable category within immunotherapy is checkpoint inhibitors, which play a pivotal role in blocking the evasion of...

Immunotherapy has emerged as a promising area of cancer treatment that leverages the body's own immune system to fight cancer cells. Unlike traditional chemotherapy, which often indiscriminately kills both cancerous...

Opdivo (nivolumab) and Yervoy (ipilimumab) are immunotherapy medications used to treat certain types of cancer. They work by helping the immune system fight cancer cells. While these medications are generally...

The combination therapy of Opdivo (nivolumab) and Yervoy (ipilimumab) offers a significant survival benefit for patients with unresectable mesothelioma compared to traditional chemotherapy. The combined treatment of Opdivo and Yervoy...

Adoptive cell therapy (ACT) represents a promising frontier in the field of cancer immunotherapy. The fundamental concept behind ACT is to harness the power of the patient's own immune system...

Checkpoint inhibitors represent a groundbreaking class of drugs in cancer immunotherapy, including for the treatment of mesothelioma. The PD-1/PD-L1 interaction is a normal mechanism that the body uses to prevent...

Cancer vaccines represent a fascinating area of research in the fight against cancer, including mesothelioma. Pathogen Introduction: Traditional vaccines for infectious diseases often introduce a weakened or inactivated pathogen (or...

Dendritic cell therapy is a form of immunotherapy that has generated a lot of interest for its potential in treating various cancers, including mesothelioma. Dendritic cells act as messengers between...